The 3D bioprinting market is growing, majorly due to the increasing technological advancements in the healthcare and pharmaceutical industries. Also, several government regulations for improving healthcare, and increasing investments in R&D are also significant factors driving the studied market growth. 3D bioprinting is an emerging field represented by various biologically applied deposition and assembling systems, which include direct writing, photolithography, microstamping, extrusion, laser writing, stereolithography, electro-printing, microfluidics, and inkjet deposition. Healthcare is one of the major markets where 3D bioprinting is bringing a seismic change. This is majorly because of the increasing investments in healthcare applications, such as model and organ prototyping and production throughout the globe, and growing innovations in healthcare through 3D printing. Several companies are undergoing extensive R&D expenditures to boost the market growth by making significant product developments and innovations. For instance, Organovo, a medical laboratory and research company, has been at the front of the R&D of 3D bioprinting in the country.

1. INTRODUCTION

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY

4. MARKET INSIGHTS

5. MARKET DYNAMICS

6. MARKET SEGMENTATION

7. COMPETITIVE LANDSCAPE

8. INVESTMENT ANALYSIS

9. FUTURE OF THE MARKET